Terumo : Revises Upward Interim Dividends and Year-End Dividends Forecast for the Fiscal Year Ending March 31, 2018

November 9, 2017

TOKYO, JAPAN - November 9, 2017 - Terumo Corporation (TSE: 4543) resolved, at its Board of Directors meeting held on November 9, 2017, the interim dividends and year-end dividends forecast for the fiscal year ending March 31, 2018 as follows.

1. Details of Interim Dividends

   Decided dividends	Latest dividends forecast (as of May 10, 2017)	FY 2017 Interim dividends (Actual)
   Record date	September 30, 2017	September 30, 2017	September 30, 2016
   Dividends per share	¥23.00	¥22.00	¥20.00
   Total amount of dividends	¥8,095 million	-	¥7,259 million
   Dividends payment starting date	December 5, 2017	-	December 7, 2016
   Source of dividends	Retained earnings	-	Retained earnings

2. Details of Dividends Forecast Modifications

   Dividends per share
   Record date	End of 2nd quarter	Year-end	Annual
   Prior forecast	¥22.00	¥22.00	¥44.00
   Revised forecast	¥23.00	¥46.00
   FY 2017 actual (ending March 31, 2018)	¥23.00
   FY 2016 actual (ended March 31, 2017)	¥20.00	¥22.00	¥42.00

3. Reasons for Modifications

Terumo considers the distribution of an appropriate amount of profit to shareholders to be one of the principal responsibilities of management and pays dividends in accordance with a policy of stably and steadily increasing dividends with a target payout ratio of 30% over the medium to long-term. Based on the policy and financial results, Terumo decided the interim dividends of ¥23 per share and the year-end dividends forecast of ¥23 per share respectively.

Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with over $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use.

Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts on projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition. The market share information in this press release is partly derived from our own independent research.

###